ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $5,051,311 | +18.2% | 258,115 | -3.6% | 1.98% | +66.1% |
Q3 2022 | $4,274,000 | +24.0% | 267,794 | +6.9% | 1.19% | -17.9% |
Q2 2022 | $3,446,000 | -27.6% | 250,466 | -16.5% | 1.45% | +90.9% |
Q1 2022 | $4,758,000 | +32.1% | 300,000 | +81.8% | 0.76% | -41.8% |
Q4 2021 | $3,602,000 | +50.2% | 165,000 | +105.7% | 1.31% | +115.8% |
Q3 2021 | $2,398,000 | -54.9% | 80,228 | -33.1% | 0.61% | -68.2% |
Q2 2021 | $5,315,000 | +40.9% | 120,000 | +41.2% | 1.90% | +48.6% |
Q1 2021 | $3,771,000 | -34.5% | 85,000 | -19.0% | 1.28% | -58.0% |
Q4 2020 | $5,758,000 | – | 105,000 | – | 3.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |